Literature DB >> 14710014

Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.

Eberhard Stennert1, Claus Wittekindt, Jens Peter Klussmann, Georg Arnold, Orlando Guntinas-Lichius.   

Abstract

OBJECTIVES/HYPOTHESIS: Histopathological characteristics and proliferation indices of recurrent pleomorphic adenoma were described in a series of 31 patients who were referred to the authors' clinic for revision surgery. STUDY
DESIGN: Prospective series of 31 patients.
METHODS: Serial sections of surgical specimen using the whole-organ sectioning technique were carried out for light microscopic examination after total parotidectomy and periparotid fat resection. The nodules were examined with special reference to localization, amount, size, histological subtypes, capsular alterations, and the amount of nodule spilling. Expression of proliferation markers (Ki67/MIB-1) according to the size and histological subtypes of the nodules was also investigated.
RESULTS: Most recurrences were multinodular, and the number of nodules was much higher than expected, ranging from 1 to 157. The myxoid subtype was predominant. Eighty percent of the patients exhibited widely distributed nodules also lying outside the scar. These nodules contained only a thin pseudocapsule and often lacked complete encapsulation. The majority of multinodular recurrences of parotid pleomorphic adenoma consisted of small nodules (less than 1 mm in diameter). Smaller nodules showed similar or higher levels of proliferative activity than larger nodules.
CONCLUSION: The extended multifocal distribution of tumor recurrences after insufficient resection of pleomorphic adenoma (most often after enucleation) can explain a high incidence of further recurrences. Therefore, a total parotidectomy including removal of surrounding fat tissue seems to be appropriate for the initial treatment of recurrent pleomorphic adenoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14710014     DOI: 10.1097/00005537-200401000-00030

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  16 in total

1.  Multinodular neck recurrence of parotid gland pleomorphic adenoma: a case report.

Authors:  Nick Papadogeorgakis; Evagelos F Kalfarentzos; Vassilis Petsinis; Eleni Parara; Maria-Emmanouela Kopaka
Journal:  Oral Maxillofac Surg       Date:  2011-06-10

2.  Stationary facial nerve paresis after surgery for recurrent parotid pleomorphic adenoma: a follow-up study of 219 cases in Denmark in the period 1985-2012.

Authors:  Anders Nøhr; Simon Andreasen; Marianne Hamilton Therkildsen; Preben Homøe
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-12       Impact factor: 2.503

3.  Differing Lymphatic Vessels Density in Salivary Adenoid Cystic Carcinoma and Pleomorphic Adenoma.

Authors:  Richard Salzman; I Stárek; L Kučerová; A Skálová
Journal:  Pathol Oncol Res       Date:  2016-11-11       Impact factor: 3.201

4.  Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.

Authors:  R Salzman; I Stárek; L Kučerová; A Skálová; J Hoza
Journal:  Virchows Arch       Date:  2014-01       Impact factor: 4.064

5.  [Pleomorphic adenoma: pitfalls and clinicopathological forms of progression].

Authors:  S Ihrler; S Schwarz; P Zengel; O Guntinas-Lichius; T Kirchner; C Weiler
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

6.  Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland.

Authors:  G Moonis; P Patel; Y Koshkareva; J Newman; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

7.  Recurrent Parotid Pleomorphic Adenomas: Our Clinical Experience.

Authors:  Özgür Kümüş; Ahmet Ömer İkiz; Sülen Sarıoğlu; Taner Kemal Erdağ
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-09-01

8.  Pleomorphic adenoma of the accessory parotid gland misdiagnosed as glomus tumour.

Authors:  Eleftherios Koudounarakis; Alexander Karatzanis; Vasileios Nikolaou; George Velegrakis
Journal:  JRSM Short Rep       Date:  2013-03-18

9.  Massive transcranial parotid pleomorphic adenoma: recurrence after 30 years.

Authors:  Graham M Strub; Alexandros Georgolios; Robert S Graham; Celeste N Powers; Daniel H Coelho
Journal:  J Neurol Surg Rep       Date:  2012-10

10.  Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature.

Authors:  Luca Oscar Redaelli de Zinis; Michela Piccioni; Antonino Roberto Antonelli; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.